Related Experiment Video
Updated: Sep 9, 2025

06:24
Establishing 3D Endometrial Organoids from the Mouse Uterus
Published on: January 6, 2023
6.6K
In Vivo Shadows and In Vitro Light: The Early Embryological Journey Amid Endometriosis.
Grzegorz Mrugacz1, Aleksandra Mospinek2, Maria Modrzyńska-Olejniczak2
1Center for Reproductive Medicine Bocian, Białystok Branch, 26 Akademicka St., 15-267 Białystok, Poland.
Biology
|September 4, 2025
Summary
Endometriosis affects fertility via inflammation and oxidative stress, impacting egg and embryo quality. In vitro fertilization (IVF) shows varied success, but new AI and immunomodulation strategies offer hope for improved patient care.
Area of Science:
- Reproductive Endocrinology
- Immunology
- Genetics
Background:
- Endometriosis presents complex challenges to female fertility, involving chronic inflammation, oxidative stress, and anatomical distortions.
- These factors adversely affect oocyte quality, embryo development, and successful implantation, complicating natural conception.
- In vitro fertilization (IVF) provides a controlled setting to mitigate some in vivo fertility barriers associated with endometriosis.
Purpose of the Study:
- To systematically review the impact of endometriosis on oocyte dysfunction and IVF outcomes.
- To evaluate current and emerging strategies for improving fertility in endometriosis patients undergoing assisted reproductive technologies.
- To identify gaps in personalized prognosis and targeted therapeutic approaches for endometriosis-related infertility.
Main Methods:
- Systematic literature review focusing on endometriosis, oocyte quality, embryo development, implantation, and IVF outcomes.
- Analysis of evidence regarding the mechanisms of endometriosis-associated infertility, including inflammatory and oxidative pathways.
- Exploration of innovative technologies such as AI-driven embryo selection, single-cell omics, and immunomodulation.
Main Results:
- Endometriosis is linked to impaired oocyte quality and reduced embryo development, contributing to lower IVF success rates.
- IVF outcomes in endometriosis patients are variable, influenced by disease severity and specific treatment protocols.
- Emerging technologies like AI embryo selection and immunomodulatory therapies show potential for enhancing IVF success.
Conclusions:
- Despite advancements, personalized prognosis and targeted therapies for endometriosis-related infertility require further development.
- Innovative tools such as AI, single-cell omics, and immunomodulation offer promising avenues for improving fertility outcomes.
- A patient-centered approach integrating scientific evidence with personalized care is crucial for managing endometriosis and infertility.
Related Concept Videos
Oogenesis
64.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.3K
Cleavage and Blastulation
45.7K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
45.7K
Development of the Sexual Organs in the Embryo and Fetus
1.4K
Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
1.4K
Ovarian Cycle
1.8K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.8K
Gastrulation
58.5K
Gastrulation establishes the three primary tissues of an embryo: the ectoderm, mesoderm, and endoderm. This developmental process relies on a series of intricate cellular movements, which in humans transforms a flat, “bilaminar disc” composed of two cell sheets into a three-tiered structure. In the resulting embryo, the endoderm serves as the bottom layer, and stacked directly above it is the intermediate mesoderm, and then the uppermost ectoderm. Respectively, these tissue strata...
58.5K
Proliferative Phase
752
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
752

